Blog
RSS FeedPosted by Michael Wonder on 26 Sep 2021
Australia secures supply of drug that treats arthritis and Covid
25 September 2021 - Health Minister Greg Hunt has secured an extra supply of a rheumatoid arthritis drug to treat critically ...
Posted by Michael Wonder on 21 Sep 2021
Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19
21 September 2021 - Joint Procurement Agreement enables European countries to purchase bamlanivimab and etesevimab directly from Lilly, in varying ...
Posted by Michael Wonder on 15 Sep 2021
Lilly to supply 388,000 doses of etesevimab to U.S. Government for treatment of COVID-19
15 September 2021 - Additional doses of etesevimab will be paired with existing bamlanivimab purchased by the U.S. Government ...
Posted by Michael Wonder on 15 Sep 2021
Regeneron announces new U.S. Government agreement to purchase additional doses of REGEN-COV (casirivimab and imdemivab) antibody cocktail
14 September 2021 - New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly ...
Posted by Michael Wonder on 14 Sep 2021
Access Consortium: alignment with ICMRA consensus on immunobridging for authorising new COVID-19 vaccines
14 September 2021 - Placebo controlled disease outcome trial data are the gold standard for authorising vaccines. However, for COVID-19 ...
Posted by Michael Wonder on 14 Sep 2021
Limiting the impact on Kiwis as API leaves the NZ market
14 September 2021 - PHARMAC is working hard to limit the impact on over 1 million Kiwis who currently take ...
Posted by Michael Wonder on 13 Sep 2021
TLV is commissioned to secure access to antibiotics
13 September 2021 - TLV, the Swedish Public Health Agency and the Medical Products Agency have been commissioned by the Government ...
Posted by Michael Wonder on 13 Sep 2021
UK terminates Valneva COVID-19 vaccine supply agreement
13 September 2021 - The UK government has terminated its supply agreement with French firm Valneva for its COVID-19 vaccine ...
Posted by Michael Wonder on 06 Sep 2021
Four million Pfizer doses arrive to super-charge vaccine roll out
6 September 2021 - Four million extra Pfizer-BioNTech (Pfizer) vaccine doses will begin arriving in Australia in days following a historic ...
Posted by Michael Wonder on 06 Sep 2021
New Zealand’s tocilizumab supply to be paused
6 September 2021 - PHARMAC has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New ...
Posted by Michael Wonder on 30 Aug 2021
Biogen offers free Alzheimer's drug as Medicare payment uncertainty remains
30 August 2021 - Biogen is providing its controversial and expensive new Alzheimer's drug free of charge for some patients amid ...
Posted by Michael Wonder on 24 Aug 2021
Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech/Pfizer and Moderna
24 August 2021 - EMA’s CHMP has adopted recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the ...
Posted by Michael Wonder on 19 Aug 2021
Booster shots ‘make a mockery of vaccine equity,’ the WHO’s Africa director says
19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...
Posted by Michael Wonder on 18 Aug 2021
WHO calls on Roche to ensure fair access to COVID-19 drug amid shortage
18 August 2021 - The World Health Organization called on Wednesday on Roche to ensure fair distribution of its arthritis ...
Posted by Michael Wonder on 18 Aug 2021
Update on Actemra (tocilizumab) supply in the U.S.
16 August 2021 - The unprecedented surge in worldwide demand and supply constraints driven by Delta variant spikes in much ...